by valethealth | Jun 8, 2021 | Press Release
Performance Cell Manufacturing was contracted to manufacture stem cells for multiple clinical trials to treat COVID-19 induced acute respiratory distress syndrome (ARDS). The most recent clinical trial approval comes from the Brazilian Health Regulatory Agency...
by valethealth | May 13, 2021 | Press Release
Performance Cell Manufacturing was contracted to manufacture stem cells for an FDA-approved stem cell clinical trial to treat COVID-19 induced acute respiratory distress syndrome (ARDS). The clinical trial, which was developed by Personalized Stem Cells, Inc. (PSC)...
by valethealth | Mar 12, 2021 | Press Release
Performance Cell Manufacturing (PCM), a contract development and manufacturing organization, recently manufactured and is providing stem cell doses for use in an FDA approved COVID-19 clinical trial. The clinical trial, which is being conducted by Sorrento...
by valethealth | Feb 9, 2021 | Press Release
Sorrento Therapeutics (Nasdaq: SRNE, “Sorrento”) announced positive results from the first patients treated in its COVID-19 clinical trial using stem cells licensed from and provided by Personalized Stem Cells, Inc. (PSC). The stem cell platform and FDA...
by valethealth | Jan 12, 2021 | Press Release
Performance Cell Manufacturing (PCM) recently completed a stem cell manufacturing contract for an FDA approved stem cell clinical trial for knee osteoarthritis. Manufacturing for the trial included processing adipose tissue (lipoaspirate) from 38 patients to produce...
by valethealth | Jan 8, 2021 | Press Release
Performance Cell Manufacturing (PCM), a contract development manufacturing organization division of VetStem Biopharma, announced that the facility they utilize for cGMP cell production is approved by the California Department of Public Health, Food and Drug Branch for...
